Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E21.34 EPS (ttm)2.59 Insider Own0.10% Shs Outstand1.59B Perf Week0.14%
Market Cap88.03B Forward P/E14.27 EPS next Y3.88 Insider Trans10.09% Shs Float1.57B Perf Month5.62%
Income4.17B PEG2.31 EPS next Q0.77 Inst Own80.70% Short Float5.35% Perf Quarter2.87%
Sales19.26B P/S4.57 EPS this Y-23.10% Inst Trans15.94% Short Ratio8.23 Perf Half Y12.20%
Book/sh3.27 P/B16.91 EPS next Y22.74% ROA14.50% Target Price67.13 Perf Year34.11%
Cash/sh6.43 P/C8.59 EPS next 5Y9.23% ROE92.70% 52W Range40.87 - 57.83 Perf YTD7.26%
Dividend1.68 P/FCF39.55 EPS past 5Y0.00% ROI23.20% 52W High-4.41% Beta-
Dividend %3.04% Quick Ratio2.70 Sales past 5Y- Gross Margin76.40% 52W Low35.25% ATR0.76
Employees25000 Current Ratio2.80 Sales Q/Q5.00% Oper. Margin31.20% RSI (14)53.32 Volatility0.90% 1.45%
OptionableYes Debt/Eq2.83 EPS Q/Q3.00% Profit Margin21.70% Rel Volume0.74 Prev Close55.60
ShortableYes LT Debt/Eq2.77 EarningsJul 25 BMO Payout61.80% Avg Volume10.24M Price55.28
Recom1.80 SMA202.23% SMA501.61% SMA2007.65% Volume7,487,200 Change-0.58%
28-Jul-14Upgrade UBS Neutral → Buy $57 → $67
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
31-Aug-14 06:30AM  Avoid taxes? 10 things to know about inversions at USA TODAY
30-Aug-14 08:31AM  The Most Interesting Man Revolutionizing The Health World at Forbes
29-Aug-14 06:08PM  [$$] Medtronic, AbbVie to Reimburse for Inversion-Triggered Taxes at The Wall Street Journal
05:41PM  [$$] Medtronic, AbbVie to Reimburse Executives for Inversion-Triggered Taxes at The Wall Street Journal
08:49AM  Buffett's 'Burger Tim' Inversion Adds Tax Bonus For Shareholders--Think Free Curly Fries at Forbes
28-Aug-14 01:52PM  I Am Sure This Pharma-Company Suits Your Portfolio Gurufocus
27-Aug-14 03:20PM  Rep. Paul Ryan: America is not as competitive as it needs to be Yahoo Finance
03:20PM  Rep. Paul Ryan on tax inversions Yahoo Finance
12:03PM  Bristol-Myers Hepatitis C Therapy Approved in EU at Investor's Business Daily
02:10AM  Whopper Reason Shareholders Should Hate Inversions? (Hint, It's Not About Patriotism) at Forbes
26-Aug-14 05:05PM  Deep Tax Cuts Opens Northern Front for U.S. Companies Bloomberg
10:54AM  Deep Tax Cuts Opens Northern Front for U.S. Companies Bloomberg
08:50AM  Deep Tax Cuts Opens Northern Front for U.S. Companies Bloomberg
12:00AM  Deep Tax Cuts Opens Northern Front for U.S. Companies Bloomberg
25-Aug-14 09:31PM  Burger King, Tim Hortons shares soar on deal talks at USA TODAY
07:43PM  Burger King, Tim Hortons shares soar on deal talks at USA TODAY
05:59PM  Burger King stock soars on whopper of a tax deal at USA TODAY
05:21PM  Tim Hortons Targeted as U.S. Tax Inversion Heads North at Bloomberg
04:38PM  Burger King stock soars on whopper of a tax deal at USA TODAY
01:31PM  Burger King deal could be a tax dodge whopper at CNBC
01:25PM  Burger King stock soars on whopper of a tax deal at USA TODAY
01:23PM  Why Burger King Isn't Like Walgreen In Tax Inversions at Investor's Business Daily
01:23PM  Video: Why Burger King Isn't Walgreen For Inversion at Investor's Business Daily
01:23PM  Video: Why Burger King Isn't Like Walgreen In Tax Inversions at Investor's Business Daily
12:52PM  Burger King eyes Tim Hortons for tax inversion deal at USA TODAY
12:37PM  Burger King Inversion Deal With THI is the Whole Whopper, Says Investors StockTwits
08:31AM  Burger King eyes Tim Hortons for tax inversion deal at USA TODAY
23-Aug-14 07:00AM  A Shift in Health-Care M&A Activity Morningstar
22-Aug-14 01:55PM  What You Need To Know About New Restrictions On Hydrocodone Combinations at Forbes
01:55PM  New Rules For Hydrocodone: What You Should Know at Forbes
21-Aug-14 07:02PM  U.S. to tighten restrictions on common opioid painkillers Reuters
05:18PM  [video] David Marcus Discusses the Policy Aspects of Corporate Inversions at TheStreet
04:23PM  ABBVIE INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation EDGAR Online
09:55AM  [video] Cramer's Stop Trading: Gilead Sciences at CNBC
18-Aug-14 12:43PM  [video] Latest motif: Tax inversion targets at CNBC
11:00AM  AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards PR Newswire
12:00AM  UK Says Sovaldi Is Worth It. We Should Listen. at Forbes
15-Aug-14 07:02PM  Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing at Bloomberg
06:10PM  Biotech Leader Gilead Sciences Scores Sovaldi Win at Investor's Business Daily
05:44PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
03:12PM  INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm Business Wire
01:51PM  IRS to probe Valeant tax returns after Canada deal at Financial Times
01:04PM  ABBVIE INC. Financials EDGAR Online Financials
12:23PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
14-Aug-14 11:13AM  Schumer Details Interest Deduction Limits in Inversions at Bloomberg
13-Aug-14 02:37PM  [video] Tax inversion hot spots at CNBC
12:58PM  AbbVie-Shire Deal Still Offers Big Tax Savings Even Without an Inversion at The Wall Street Journal
10:49AM  Pharmacyclics Has Edge Over Blood Cancer Competitors at TheStreet
09:40AM  [video] Faber Report: New wave of tax inversions? at CNBC
11-Aug-14 02:33PM  Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment Accesswire
01:03PM  3 Health Care Stocks Nudging The Sector Higher at TheStreet
08-Aug-14 04:45PM  GW Pharma, Insys Face Off In Cannabis Drug Space at Investor's Business Daily
01:50PM  US groups ponder the great tax escape at Financial Times
01:05PM  Shire drops on doubt over AbbVie takeover at Financial Times
07:07AM  Biotech firm Galapagos says GSK stops joint drug project Reuters
07-Aug-14 09:40PM  Stampede of Mergers Could Mean Growth, or Irrationality, Ahead at New York Times
05:03PM  ABBVIE INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
10:00AM  Obama Joins Blame Game As Companies Flee U.S. For Lower Tax Rates at Forbes
06-Aug-14 09:59PM  Obama: Congress should end 'tax inversions' at USA TODAY
04:15PM  Walgreen Stays in U.S. as It Buys Rest of Alliance Boots Bloomberg
01:46PM  [$$] Billions Vaporized as Merger Deals Fall Apart at Barrons.com
01:43PM  Pharma shares slide on fears of 'tax inversion' clampdown at Financial Times
10:15AM  Walgreen Leads Sell-Off In 'Tax Inversion' Stocks at Investor's Business Daily
10:15AM  Walgreen Dives As Drugstore Buys Boots Without Tax Shift Investor's Business Daily
09:36AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
09:05AM  Walgreen Stays in U.S. as It Buys Rest of Alliance Boots Bloomberg
09:05AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
08:35AM  Shire shares slide on fears of 'tax inversion' clampdown at Financial Times
08:27AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
07:41AM  Walgreens to stay rooted in U.S. as it buys Alliance Boots at CNNMoney.com
05-Aug-14 08:09PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
07:28PM  Obama Is Considering Bypassing Congress To Try To Stop Companies From Leaving America To Save On Taxes Business Insider
06:22PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
06:04PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
05:38PM  Drug company won't appeal gay rights ruling to top U.S. court Reuters
04:50PM  AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU Zacks
04:36PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
04:13PM  Report: Walgreens won't tap lucrative tax loophole at USA TODAY
04:03PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
03:26PM  Walgreen Seen Rejecting Tax Inversion Amid Pressure at Investor's Business Daily
12:11PM  Obama Weighing Options to Stop Corporate Tax Flight at New York Times
12:11PM  Obama Studying Administrative Action on Corporate Inversions at New York Times
12:11PM  Democrats Ask Obama to Act on Corporate Inversions at New York Times
12:11PM  Democrats Ask Obama to Act on Corporate Inversions at New York Times
09:35AM  Cannabis Technologies Looks to Capitalize on Therapeutics Accesswire
02:38AM  Altogether Now: U.S. Tax Code Is A Rotting Carcass at Forbes
02:38AM  All Together Now: U.S. Tax Code Is A Rotting Carcass at Forbes
04-Aug-14 12:29PM  Walgreen Names New CFO Ahead of Possible Inversion at Investor's Business Daily
10:56AM  Amgen Cancer Drug Kyprolis Succeeds In Trial at Investor's Business Daily
09:08AM  Goldman Sachs hires former Barclays M&A banker at MarketWatch
08:29AM  [$$] AbbVie Brain Tumor Treatment Gets Orphan Designation at The Wall Street Journal
08:00AM  AbbVie Receives EMA and FDA Orphan Drug Designation for Investigational Compound ABT-414 in the Treatment of Glioblastoma Multiforme PR Newswire
01-Aug-14 12:35PM  Pharmacyclics Q2 Earnings Get Mixed Reception at Investor's Business Daily
10:00AM  AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program PR Newswire
31-Jul-14 01:30PM  Drug pricing: Bitter pill at Financial Times
09:42AM  Moving overseas is a last resort for U.S. companies Yahoo Finance
08:26AM  The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene Zacks
04:06AM  AstraZeneca raises forecasts after seeing off Pfizer Reuters
30-Jul-14 02:56AM  More People -- And Now Companies -- Exit U.S. Taxes at Forbes
02:56AM  More People - And Now Companies - Exit U.S. Taxes at Forbes
AbbVie Inc., a research-based biopharmaceutical company, is engaged in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor that is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM